Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Endicott

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Structure (London, England : 1993)|April 15, 1995
The cell cycle and suc1: from structure to function?J A Endicott, P Nurse
Annual Review of Biochemistry|January 1, 1989
The biochemistry of P-glycoprotein-mediated multidrug resistanceJ A Endicott, V Ling
Pharmacology & Therapeutics|August 24, 1999
Chemical inhibitors of cyclin-dependent kinases: insights into design from X-ray crystallographic studiesM E Noble, J A Endicott
Structure (London, England : 1993)|June 23, 1998
Structural principles in cell-cycle control: beyond the CDKsJ A Endicott, M E Noble
DNA Sequence : the Journal of DNA Sequencing and Mapping|January 1, 1991
Complete cDNA sequences encoding the Chinese hamster P-glycoprotein gene familyJ A Endicott, F Sarangi, V Ling
Protein Engineering|February 1, 1994
Mutational analysis supports a structural model for the cell cycle protein kinase p34J A Endicott, P Nurse, L N Johnson
Current Opinion in Structural Biology|December 23, 1999
Cyclin-dependent kinases: inhibition and substrate recognitionJ A Endicott, M E Noble, J A Tucker
Nature Cell Biology|November 24, 1999
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinasesN R Brown, M E Noble, J A Endicott, et al.
Trends in Biochemical Sciences|January 20, 1998
The cyclin box fold: protein recognition in cell-cycle and transcription controlM E Noble, J A Endicott, N R Brown, et al.
Oncogene|June 25, 2008
CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinasesK Bettayeb, N Oumata, A Echalier, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Structure (London, England : 1993)|April 15, 1995
The cell cycle and suc1: from structure to function?J A Endicott, P Nurse
Annual Review of Biochemistry|January 1, 1989
The biochemistry of P-glycoprotein-mediated multidrug resistanceJ A Endicott, V Ling
Pharmacology & Therapeutics|August 24, 1999
Chemical inhibitors of cyclin-dependent kinases: insights into design from X-ray crystallographic studiesM E Noble, J A Endicott
Structure (London, England : 1993)|June 23, 1998
Structural principles in cell-cycle control: beyond the CDKsJ A Endicott, M E Noble
DNA Sequence : the Journal of DNA Sequencing and Mapping|January 1, 1991
Complete cDNA sequences encoding the Chinese hamster P-glycoprotein gene familyJ A Endicott, F Sarangi, V Ling
Protein Engineering|February 1, 1994
Mutational analysis supports a structural model for the cell cycle protein kinase p34J A Endicott, P Nurse, L N Johnson
Current Opinion in Structural Biology|December 23, 1999
Cyclin-dependent kinases: inhibition and substrate recognitionJ A Endicott, M E Noble, J A Tucker
Nature Cell Biology|November 24, 1999
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinasesN R Brown, M E Noble, J A Endicott, et al.
Trends in Biochemical Sciences|January 20, 1998
The cyclin box fold: protein recognition in cell-cycle and transcription controlM E Noble, J A Endicott, N R Brown, et al.
Oncogene|June 25, 2008
CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinasesK Bettayeb, N Oumata, A Echalier, et al.
Pageof 3